University of Nove de Julho   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Sao Paulo Brazil (1972)

Organization Overview

First Clinical Trial
2013
NCT02414464
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Adriana da Silva Magalhaes | Daniela de Fátima Teixeira da Silva | Daysi Tobelem | Leonardo Paroche de Matos | LUCIANA MARIA MALOSA SAMPAIO | Nove de Julho University | Nove de Julho university (UNINOVE) | Nove de Julho University (Uninove) | University of Nove de Julho

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 2)

Dental Caries (Phase 1)

Metabolic Syndrome (Phase 4)

Obesity, Abdominal (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 21
  • # of Trial APIs: 22